Inhaled corticosteroids do not affect behaviour

T W de Vries1, E N van Roon, E J Duiverman

  • 1Department of Pediatrics, Medical Centre Leeuwarden, Leeuwarden, The Netherlands. tjalling.de.vries@znb.nl

Insights

Children with asthma using inhaled corticosteroids (ICS) show more behavioral issues than healthy children. However, these differences are not significant when compared to children seeking care for other conditions, suggesting specialist care may influence behavior.

Area of Science:

  • Pediatric Psychology
  • Respiratory Medicine

Background:

  • Asthma affects numerous children globally.
  • Inhaled corticosteroids (ICS) are a primary treatment for pediatric asthma.
  • Concerns exist regarding potential behavioral side effects of ICS.

Purpose of the Study:

  • To investigate if children with asthma on ICS exhibit increased behavioral problems.
  • To compare behavioral issues in children on ICS with healthy controls and children receiving care for other conditions.

Main Methods:

  • A comparative study involving three groups: asthmatic children on ICS, children attending an ENT clinic, and healthy controls.
  • Utilized questionnaires including the Child Behavior Checklist (CBCL) and ADHD rating scales.
  • Collected data on health, medication, demographics, and behavior.

Main Results:

  • Asthmatic children on ICS had significantly higher total CBCL and mean ADHD scores compared to healthy controls.
  • No significant differences in behavioral scores were found between children on ICS and those attending the ENT clinic.
  • Specific differences were noted in CBCL-axes between the ICS group and healthy controls, but not the ENT group.

Conclusions:

  • Children with asthma on ICS demonstrate distinct behavioral patterns compared to healthy children.
  • Behavioral differences may be linked to individual susceptibility or the impact of specialist care rather than ICS directly.
  • Further research is needed to elucidate the relationship between asthma, ICS treatment, and behavioral outcomes.
Abstract

Related Concept Videos

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...